2020
DOI: 10.1016/j.bbadis.2018.11.024
|View full text |Cite
|
Sign up to set email alerts
|

Biology of preeclampsia: Combined actions of angiogenic factors, their receptors and placental proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
12
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 29 publications
(15 citation statements)
references
References 80 publications
1
12
0
2
Order By: Relevance
“…However, insights into the pathophysiology and diagnosis of these syndromes are still missing, which often leads to premature births with all its consequences. In addition, also affected women may have long-term health problems such as risk disposition for cardiovascular diseases [ 40 , 41 , 42 , 43 ]. Hence, finding specific diagnostic and curative treatments for the mother and fetus is a demanding task, requiring systemic studies of the placenta and the feto–maternal interface using innovative study designs.…”
Section: Discussionmentioning
confidence: 99%
“…However, insights into the pathophysiology and diagnosis of these syndromes are still missing, which often leads to premature births with all its consequences. In addition, also affected women may have long-term health problems such as risk disposition for cardiovascular diseases [ 40 , 41 , 42 , 43 ]. Hence, finding specific diagnostic and curative treatments for the mother and fetus is a demanding task, requiring systemic studies of the placenta and the feto–maternal interface using innovative study designs.…”
Section: Discussionmentioning
confidence: 99%
“…The usefulness of Lgals13 as a biomarker for PE has been questioned as late second-trimester Lgals13 alone does not increase the ability to predict PE when compared to second-trimester Doppler pulsatility index and other potential biochemical markers (168), highlighting the need to consider the interactions between different signaling pathways in disease pathogenesis when in search for sensitive, reliable biomarkers. In this regard, recent studies suggest that the kinetics of Lgals13 expression in PE would result from the concerted actions of this protein and antiangiogenic factors as sFlt-1 on the maternal vascular system, with a dual role for Lgals13: first in low levels acting as a priming insult promoting endothelial activation and angiogenic imbalance, and increasing later in the third trimester as a natural rescue response promoting maternal vasodilation to lower blood pressure (169). In the context of gestational diabetes mellitus (GDM), increased Lgals13 serum levels during the early second trimester and lower expression in trophoblast cells of the term placenta have been reported (170, 171).…”
Section: Galectin 13 (Lgals13)mentioning
confidence: 99%
“…As predictors of preeclampsia, these factors work better for early preeclampsia than late preeclampsia, and, generally speaking, as pregnancy nears term, the distinction between normal and abnormal based on angiogenic factors becomes blurred. 63 Moreover, the angiogenic factors are systemically expressed in the human body and have been used for the prediction and diagnosis of many other diseases such as chronic renal disease, several malignancies, sepsis, subarachnoid hemorrhage, and pancreatitis. This shows that the imbalance between pro-and antiangiogenic factors is not specific to preeclampsia.…”
Section: Toward a New Frameworkmentioning
confidence: 99%